India, Aug. 1 -- The nutraceutical industry is undergoing a transformation, and cognitive health has emerged as its most strategic frontier. As populations age and neurological disorders rise, the focus has decisively shifted from physical to mental longevity. Brain health is no longer a soft segment driven by consumer wellness fads-it is fast becoming a core pillar of clinical nutrition portfolios, preventive health strategies, and biotech-adjacent investment theses.

What makes this particularly significant for B2B players is the convergence of three high-impact forces: scientific validation, regulatory urgency, and unmet market demand in early-stage cognitive decline and Alzheimer's resilience. For nutraceutical suppliers, contract for...